Literature DB >> 10462240

The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant.

E Y Enioutina1, D Visic, Z A McGee, R A Daynes.   

Abstract

Systemic and mucosal immune responses were effectively induced following the subcutaneous administration of Haemophilus influenzae type b oligosaccharide conjugated to diphtheria toxoid vaccine in a formulation containing the active form of vitamin D3. IgA and IgG antibodies with specificity for both the protein and oligosaccharide components of the vaccine were detectable in mucosal secretions following immunization. The IgA and IgG mucosal antibodies were produced locally, and were functional as demonstrated by their diphtheria toxin neutralizing activity. Our data suggests that subcutaneous tissues can effectively serve as effective antigen presenting sites for both mucosal and systemic immune responses to antigens administered in combination with vitamin D3.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462240     DOI: 10.1016/s0264-410x(99)00147-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Mucosal and systemic adjuvant activity of alphavirus replicon particles.

Authors:  Joseph M Thompson; Alan C Whitmore; Jennifer L Konopka; Martha L Collier; Erin M B Richmond; Nancy L Davis; Herman F Staats; Robert E Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

3.  TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines.

Authors:  Elena Y Enioutina; Diana Bareyan; Raymond A Daynes
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

4.  Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Megan M O'Byrne; Robert M Jacobson; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-20       Impact factor: 3.641

5.  Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses.

Authors:  John D Clements; Lucy C Freytag
Journal:  Clin Vaccine Immunol       Date:  2016-06-06

6.  Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Seunghyun Won; Rachel Lee; Tahaniyat Lalani; Anuradha Ganesan; Timothy Burgess; Brian K Agan
Journal:  Vaccine       Date:  2016-08-28       Impact factor: 3.641

7.  Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node.

Authors:  Joseph M Thompson; Michael G Nicholson; Alan C Whitmore; Melodie Zamora; Ande West; Akiko Iwasaki; Herman F Staats; Robert E Johnston
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  Vitamin D, leptin and impact on immune response to seasonal influenza A/H1N1 vaccine in older persons.

Authors:  Sapna P Sadarangani; Inna G Ovsyannikova; Krista Goergen; Diane E Grill; Gregory A Poland
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 9.  "Let there be light": the role of vitamin D in the immune response to vaccines.

Authors:  Sapna P Sadarangani; Jennifer A Whitaker; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2015-08-31       Impact factor: 5.217

10.  1alpha,25-dihydroxyvitamin D3 increases IgA serum antibody responses and IgA antibody-secreting cell numbers in the Peyer's patches of pigs after intramuscular immunization.

Authors:  Y Van Der Stede; T Verfaillie; E Cox; F Verdonck; B M Goddeeris
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.